Insilico Medicine

Last updated: February 15, 2024

Alex Zhavoronkov, CEO and co-founder
Alex Zhavoronkov, CEO and co-founder
Country: Hong Kong | Funding: $401.3M (+)

Website: http://insilicomedicine.com/

Insilico aims to apply artificial intelligence to extend human productive longevity and transform the pharmaceutical industry.